US Stock MarketDetailed Quotes

ZSANQ ZOSANO PHARMA CORP

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Dec 9 16:00 ET
980.45Market Cap0.00P/E (TTM)

ZOSANO PHARMA CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
Total revenue
-48.84%132K
250.45%785K
-61.16%87K
252K
188K
258K
224K
224K
0
0
Operating revenue
-48.84%132K
250.45%785K
-61.16%87K
--252K
--188K
--258K
--224K
--224K
--0
--0
Cost of revenue
-46.91%86K
365.50%796K
-46.20%92K
340K
202K
162K
171K
171K
0
0
Gross profit
-52.08%46K
-120.75%-11K
-109.43%-5K
-88K
-14K
96K
53K
53K
0
0
Operating expense
-8.85%7.42M
-3.93%31.52M
-13.48%6.91M
-0.25%8.51M
3.38%7.96M
-5.26%8.14M
-11.79%32.81M
-8.66%7.99M
-10.77%8.53M
-18.17%7.7M
Selling and administrative expenses
4.55%2.94M
-5.74%10.55M
-14.56%2.25M
-6.73%2.52M
6.94%2.96M
-8.70%2.81M
-5.27%11.19M
-15.02%2.64M
-11.95%2.7M
-0.04%2.77M
-General and administrative expense
4.55%2.94M
-5.74%10.55M
-14.56%2.25M
-6.73%2.52M
6.94%2.96M
-8.70%2.81M
-5.27%11.19M
-15.02%2.64M
-11.95%2.7M
-0.04%2.77M
Research and development costs
-15.93%4.48M
-3.00%20.97M
-12.95%4.66M
2.76%5.99M
1.38%5M
-3.34%5.33M
-14.82%21.62M
-5.16%5.35M
-10.21%5.82M
-25.72%4.93M
Operating profit
8.34%-7.38M
3.74%-31.53M
12.84%-6.92M
-0.79%-8.6M
-3.56%-7.97M
6.38%-8.05M
11.93%-32.76M
9.26%-7.94M
10.77%-8.53M
18.17%-7.7M
Net non-operating interest income expense
26.04%-71K
73.47%-186K
66.88%-52K
90.18%-16K
88.11%-22K
51.02%-96K
-121.84%-701K
3.09%-157K
32.08%-163K
-493.62%-185K
Non-operating interest income
100.00%2K
-83.33%3K
0.00%1K
-50.00%1K
--0
-90.00%1K
-91.30%18K
-75.00%1K
-95.12%2K
-93.90%5K
Non-operating interest expense
-24.74%73K
-73.71%189K
-66.46%53K
-89.70%17K
-88.42%22K
-52.91%97K
37.48%719K
-4.82%158K
-41.28%165K
442.86%190K
Other net income (expense)
-1,298,150.00%-25.96M
1,892.22%1.79M
60.00%-2K
-1,525.00%-57K
15,516.67%1.85M
-98.06%2K
218.42%90K
84.38%-5K
106.06%4K
-12K
Special income (charges)
---25.94M
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--25.94M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-1,100.00%-20K
1,892.22%1.79M
60.00%-2K
-1,525.00%-57K
15,516.67%1.85M
-98.06%2K
218.42%90K
84.38%-5K
106.06%4K
---12K
Income before tax
-310.33%-33.41M
10.32%-29.93M
13.92%-6.97M
0.22%-8.67M
22.18%-6.14M
6.30%-8.14M
11.23%-33.37M
9.42%-8.1M
11.92%-8.69M
15.65%-7.9M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-310.33%-33.41M
10.32%-29.93M
13.92%-6.97M
0.22%-8.67M
22.18%-6.14M
6.30%-8.14M
11.23%-33.37M
9.42%-8.1M
11.92%-8.69M
15.65%-7.9M
Net income continuous Operations
-310.33%-33.41M
10.32%-29.93M
13.92%-6.97M
0.22%-8.67M
22.18%-6.14M
6.30%-8.14M
11.23%-33.37M
9.42%-8.1M
11.92%-8.69M
15.65%-7.9M
Minority interest income
Net income attributable to the parent company
-310.33%-33.41M
10.32%-29.93M
13.92%-6.97M
0.22%-8.67M
22.18%-6.14M
6.30%-8.14M
11.23%-33.37M
9.42%-8.1M
11.92%-8.69M
15.65%-7.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-310.33%-33.41M
10.32%-29.93M
13.92%-6.97M
0.22%-8.67M
22.18%-6.14M
6.30%-8.14M
11.23%-33.37M
9.42%-8.1M
11.92%-8.69M
15.65%-7.9M
Basic earnings per share
-187.91%-7.86
44.90%-9.4501
25.00%-2.1
36.36%-2.45
57.14%-2.1
67.50%-2.73
78.60%-17.1503
82.61%-2.8
80.00%-3.8501
74.55%-4.9001
Diluted earnings per share
-187.91%-7.86
44.90%-9.4501
25.00%-2.1
36.36%-2.45
57.14%-2.1
67.50%-2.73
78.60%-17.1503
82.61%-2.8
80.00%-3.8501
74.55%-4.9001
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020
Total revenue -48.84%132K250.45%785K-61.16%87K252K188K258K224K224K00
Operating revenue -48.84%132K250.45%785K-61.16%87K--252K--188K--258K--224K--224K--0--0
Cost of revenue -46.91%86K365.50%796K-46.20%92K340K202K162K171K171K00
Gross profit -52.08%46K-120.75%-11K-109.43%-5K-88K-14K96K53K53K00
Operating expense -8.85%7.42M-3.93%31.52M-13.48%6.91M-0.25%8.51M3.38%7.96M-5.26%8.14M-11.79%32.81M-8.66%7.99M-10.77%8.53M-18.17%7.7M
Selling and administrative expenses 4.55%2.94M-5.74%10.55M-14.56%2.25M-6.73%2.52M6.94%2.96M-8.70%2.81M-5.27%11.19M-15.02%2.64M-11.95%2.7M-0.04%2.77M
-General and administrative expense 4.55%2.94M-5.74%10.55M-14.56%2.25M-6.73%2.52M6.94%2.96M-8.70%2.81M-5.27%11.19M-15.02%2.64M-11.95%2.7M-0.04%2.77M
Research and development costs -15.93%4.48M-3.00%20.97M-12.95%4.66M2.76%5.99M1.38%5M-3.34%5.33M-14.82%21.62M-5.16%5.35M-10.21%5.82M-25.72%4.93M
Operating profit 8.34%-7.38M3.74%-31.53M12.84%-6.92M-0.79%-8.6M-3.56%-7.97M6.38%-8.05M11.93%-32.76M9.26%-7.94M10.77%-8.53M18.17%-7.7M
Net non-operating interest income expense 26.04%-71K73.47%-186K66.88%-52K90.18%-16K88.11%-22K51.02%-96K-121.84%-701K3.09%-157K32.08%-163K-493.62%-185K
Non-operating interest income 100.00%2K-83.33%3K0.00%1K-50.00%1K--0-90.00%1K-91.30%18K-75.00%1K-95.12%2K-93.90%5K
Non-operating interest expense -24.74%73K-73.71%189K-66.46%53K-89.70%17K-88.42%22K-52.91%97K37.48%719K-4.82%158K-41.28%165K442.86%190K
Other net income (expense) -1,298,150.00%-25.96M1,892.22%1.79M60.00%-2K-1,525.00%-57K15,516.67%1.85M-98.06%2K218.42%90K84.38%-5K106.06%4K-12K
Special income (charges) ---25.94M------------------0----------------
-Less:Impairment of capital assets --25.94M------------------0----------------
Other non- operating income (expenses) -1,100.00%-20K1,892.22%1.79M60.00%-2K-1,525.00%-57K15,516.67%1.85M-98.06%2K218.42%90K84.38%-5K106.06%4K---12K
Income before tax -310.33%-33.41M10.32%-29.93M13.92%-6.97M0.22%-8.67M22.18%-6.14M6.30%-8.14M11.23%-33.37M9.42%-8.1M11.92%-8.69M15.65%-7.9M
Income tax 0000000000
Net income -310.33%-33.41M10.32%-29.93M13.92%-6.97M0.22%-8.67M22.18%-6.14M6.30%-8.14M11.23%-33.37M9.42%-8.1M11.92%-8.69M15.65%-7.9M
Net income continuous Operations -310.33%-33.41M10.32%-29.93M13.92%-6.97M0.22%-8.67M22.18%-6.14M6.30%-8.14M11.23%-33.37M9.42%-8.1M11.92%-8.69M15.65%-7.9M
Minority interest income
Net income attributable to the parent company -310.33%-33.41M10.32%-29.93M13.92%-6.97M0.22%-8.67M22.18%-6.14M6.30%-8.14M11.23%-33.37M9.42%-8.1M11.92%-8.69M15.65%-7.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -310.33%-33.41M10.32%-29.93M13.92%-6.97M0.22%-8.67M22.18%-6.14M6.30%-8.14M11.23%-33.37M9.42%-8.1M11.92%-8.69M15.65%-7.9M
Basic earnings per share -187.91%-7.8644.90%-9.450125.00%-2.136.36%-2.4557.14%-2.167.50%-2.7378.60%-17.150382.61%-2.880.00%-3.850174.55%-4.9001
Diluted earnings per share -187.91%-7.8644.90%-9.450125.00%-2.136.36%-2.4557.14%-2.167.50%-2.7378.60%-17.150382.61%-2.880.00%-3.850174.55%-4.9001
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg